Prosit Sole

PharmaceuticalsSeries BBeijing, Chinaprositsole.com

Latest round

Series B

Last raised

Feb 2021

Total raised

Undisclosed

Investors

2

About Prosit Sole

Established in 2013 and based in Beijing, China, Prosit Sole is a biotechnology company that focuses on the innovation of protein therapeutics. It has set up an R&D Center and manufacturing facility in Hebei, and a Clinical Research Center in Seattle. The company's founder and CEO, Hongyu Liu, graduated from the University of Houston and served as head of protein production in Novo Nordisk. The R&D management team has over 25 years of pharmaceutical industrial experience. The company is committed to developing innovative protein drugs. It has developed the Prositsole Protein Optimize Platform (P-POP) that contains the function of drug screening, cell banking, animal disease models, etc. There are already 6 innovative drugs in the company's product pipeline for treating rare diseases.

Who invested in Prosit Sole

2 investors across 2 rounds

See all investors in Prosit Sole

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Feb 7, 2021

    Amount

    Undisclosed

    Investors

    Locked

  2. Series A

    Nov 23, 2017

    Amount

    Undisclosed

    Investors

    Locked

Questions about Prosit Sole

Who invested in Prosit Sole?

Prosit Sole has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Prosit Sole raised?

Prosit Sole has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Prosit Sole last raise money?

Prosit Sole's most recent round on record is a Series B, in Feb 2021.

What does Prosit Sole do?

Established in 2013 and based in Beijing, China, Prosit Sole is a biotechnology company that focuses on the innovation of protein therapeutics.

Where is Prosit Sole headquartered?

Prosit Sole is headquartered in Beijing, China.

Which VCs invest in companies like Prosit Sole?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Prosit Sole's stage. Their profiles are linked below.

Raising like Prosit Sole? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.